newsfilter
← Latest News
Business Wire·

New Analysis of MRI Findings Shows UPLIZNA® (inebilizumab-cdon) Reduced the Formation of Subclinical Spinal Cord Lesions in People With Neuromyelitis Optica Spectrum Disorder (NMOSD)

-- Study shows subclinical spinal cord lesions were associated with future NMOSD attacks -- Horizon Therapeutics plc (NASDAQ:HZNP) today announced the presentation of a new analysis of MRI data from the Phase 3